C-PROWESS study
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2614550
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Combination therapy of panitumumab plus irinotecan: Patients receive panitumumab (intravenous dose of 6 mg/kg) plus intraveous infusion of irinotecan of 150 mg/m2 (body surface area). Treatment cycles are repeated every 2 weeks until disease progression, unacceptable adverse events, or withdrawal of consent.
Primary outcome(s): Response Rate
Study Design: single arm study, open(masking not used), no treatment control/standard of care control, single assignment, treatment purpose
创建时间：
2022-06-15
